Home » Rheumatological, immunological and rare patients: “No to the postponement of the second dose of the anti-Covid vaccine”

Rheumatological, immunological and rare patients: “No to the postponement of the second dose of the anti-Covid vaccine”

by admin

“Rheumatological patients are fragile subjects, which is why the recall of the anti-Covid vaccination must not be delayed. It must be carried out within the deadline established by the scientific studies available to date ”. This is what the National Association of Rheumatic Diseases – Anmar Onlus writes in a letter sent, among others, to the Minister of Health Roberto Speranza, the President of the Lazio Region Nicola Zingaretti and the Extraordinary Commissioner Francesco Paolo Figliuolo. A letter written following the news that a woman with rheumatoid arthritis from Lazio had a postponement of the administration of the second dose beyond the timelines indicated by the protocols for the Pfizer vaccine.

Covid vaccines, the experts: “No to lengthening the time between doses for fragile patients”


Not just vaccines

A not isolated fact: “We are receiving many reports of a failure to implement the vaccination program to protect patients suffering from rare and chronic diseases such as rheumatic ones”, he declares Silvia Tonolo, President Anmar: “Added to these are the many difficulties encountered by patients in priority vaccine bookings or in carrying out INPS visits for the recognition of disability. We are aware that the pandemic has overwhelmed the country and led to the collapse of regional and national health. However, today, more than a year after the declaration of emergency, it is no longer acceptable that our patients have to suffer delays in the updating of treatment plans, suspension of visits to social security institutions and now also vaccination postponements due to the inability of those who they should organize a war machine at the height of a health system so praised by other nations ”.

See also  Twitter & Celebrities - La Stampa

5 million patients

Anmar asks that the booking method be changed to allow fragile patients to always have, and not for limited periods, a preferential line. “It must also be established – continues Tonolo – that it is sufficient to self-certify, at the time of booking, the existence of a pathology clinically ascertained by accredited public or private specialists in order not to run into other bureaucratic stakes that actually jam the system. We therefore ask – he concludes – that all the Authorities take immediate action in practice and no longer only in words so that the more than 5 million rheumatological patients living in Italy are protected from a socio-health point of view in this still very difficult moment “.

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy